A network for sharing data and resources in immuno-oncology
Official title: Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
Funded at Roswell Park Cancer Institute Corp · NIH-9625289 · Data updated 2026-11-12
This study is all about finding better ways to treat cancer using the body's immune system by working together with different experts to share information, which could lead to new treatments and help patients like you have more effective options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project start | September 30, 2018 |
| Project end | August 31, 2025 |
| Funding year | 2018 |
| Award (this year) | $6,276,836 |
| NIH project number | 1U24CA232979-01 |
| Project ID | NIH-9625289 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who are undergoing treatment for cancer or are at risk of developing cancer.
✕Less likely to help
Patients with non-malignant conditions or those under 21 years old may not receive benefits from this research.
What this research studies
This research focuses on enhancing the effectiveness of immuno-oncology treatments for cancer by creating a collaborative network that shares data and resources. It aims to identify new immune targets, understand resistance mechanisms, and evaluate combination therapies through a multi-disciplinary approach. Patients may benefit from improved treatment strategies and preventive measures against cancer as the research progresses. The project will also streamline data collection and management to support ongoing cancer studies.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and preventive strategies for patients.
How similar studies have gone: Previous research in immuno-oncology has shown promising results, indicating that collaborative approaches can lead to significant advancements in cancer treatment.
Where this research is happening
-
Roswell Park Cancer Institute Corp
Buffalo, United States Active
Researchers
- Principal investigator: Hutson, Alan David — Roswell Park Cancer Institute Corp
- Study coordinator: Hutson, Alan David
Related research
Other NIH-funded projects on the same topics.
-
A network for sharing data and resources in immuno-oncology.
This study is all about bringing together experts to find better ways to treat cancer by understanding why some treatments don’t work and discovering new targets for the immune system, which could lead to more personalized and effective therapies for adults.
-
Targeting retrotransposons to help kids with hard-to-treat cancers like neuroblastoma
Aims to repurpose safe antiviral drugs to block retrotransposons in children with relapsed or refractory neuroblastoma to improve outcomes.
-
MedSupport: Helping families overcome barriers to kids' chemotherapy medicines
This program offers extra support to parents of children with acute lymphoblastic leukemia to help them give home chemotherapy medicines more reliably.
-
Innate immune cells and female lung cancer risk
A study exploring how certain immune cells in the lungs may contribute to lung cancer in young women who don’t smoke.
-
Effect of ONP filler materials on how fast nicotine is delivered
This grant tests how different filler materials in oral nicotine pouches affect how quickly nicotine is released and absorbed in the mouth.
-
Age-related dormancy genes in breast cancer using a worm model
A study looking at how aging affects dormant breast cancer cells to find genes that keep cancer asleep or trigger relapse.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.